Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185483 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-09-22 | 2023-12-08 | 204990 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-09-28 | 2023-10-06 | 205483 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-01-26 | 2024-03-01 | 217490 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223046 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223052 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Resolved | 2025-02-20 | 2025-02-28 | 250941 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Resolved | 2025-03-20 | 2025-06-20 | 253070 |
| APO-AMOXI CLAV | 250MG 125MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273341 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2018-09-09 | 44 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-13 | 49 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 636 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2017-06-05 | 2017-09-05 | 11959 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2018-02-05 | 2018-04-18 | 38473 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2017-06-26 | 2018-09-09 | 13967 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2017-11-13 | 2018-01-31 | 29028 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2018-03-27 | 2018-04-24 | 44099 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2019-01-03 | 2019-02-01 | 71103 |
| APO-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-14 | 2023-04-06 | 171836 |
| APO-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-23 | 2023-03-23 | 179437 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |